DMTK News and Press, DermTech Inc From 12/06/23

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In DermTech To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $25,000 investing in DermTech stock or options between March 8, 2021 and November 3, 2022 a...

SAN DIEGO, CA / ACCESSWIRE / December 5, 2023 / The Shareholders Foundation, Inc. announces that a deadline is coming up on December 15, 2023 in the lawsuit that was filed for certain investors in DermTech, Inc. (NASDAQ:DMTK) shares. Investors, who purchased shares in excess of $100,000 DermTec...

SAN DIEGO, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a deadline is coming up on December 15, 2023 in the lawsuit that was filed for certain investors in DermTech, Inc. (NASDAQ: DMTK) shares. Investors, who purchased shares in excess of $100,000 DermTec...

2023-11-02 19:27:06 ET DermTech, Inc. (DMTK) Q3 2023 Earnings Conference Call November 2, 2023, 5:00 pm ET Company Participants Steve Kunszabo - Head, IR Bret Christensen - President & CEO Kevin Sun - CFO Conference Call Participants Thomas Flaten...

2023-11-02 16:42:57 ET More on DermTech DermTech signs contracts with Highmark for the foundational assay of its melanoma test Seeking Alpha’s Quant Rating on DermTech For further details see: DermTech GAAP EPS of -$0.57 beats by $0.19, revenue of $3.9M in...

- Average selling price (ASP) for the DermTech Melanoma Test (DMT) increased 24 percent year-over-year - Test revenue increased 8 percent versus the third quarter of 2022 - Cash runway into the first quarter of 2025 DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), ...

Acushnet Holdings Corp. (GOLF) is expected to report $0.54 for Q3 2023 Paramount Global (PARA) is expected to report $0.09 for Q3 2023 Curis Inc. (CRIS) is expected to report $-2.32 for Q3 2023 Quanta Services Inc. (PWR) is expected to report $1.99 for Q3 2023 GRI Bio Inc. (GRI) i...

DermTech Inc (DMTK) is expected to report $-0.68 for Q3 2023

NEW YORK, Oct. 21, 2023 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of California on behalf of all persons or entities who purchased or otherwise acquired DermTech, ...

DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, will host a conference call and webcast on Thursday, November 2, 2023 at 5:00 p.m. Eastern Time (ET) to discuss the Company's third-quarter 2023 operating...